Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs

In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy lower drug prices. How long might this last? Read more at https://news.bloomberglaw.com/pharma-and-life-sciences/virus-delays-few-approvals-dry-up-generic-drug-lawsuits-in-2020 Source

Om Podcasten

DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management